Please ensure Javascript is enabled for purposes of website accessibility

Medtronic Rolls Out New Miniature Heart Monitor

By Eric Volkman – Feb 19, 2014 at 4:48PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Medtronic's Reveal LINQ ICM clears regulatory hurdles to land on the market.

After receiving the necessary regulatory approval, Medtronic (MDT -0.22%) is launching its latest product on the global market. The medical devices company announced on Wednesday that it has received clearance from the U.S. Food and Drug Administration and the European Union for its Reveal LINQ Insertable Cardiac Monitor System, which is now available for purchase.

Medtronic said in a press release that the Reveal LINQ ICM is the smallest implantable cardiac monitoring device on the market, roughly 80% smaller than competing devices. It allows doctors to remotely monitor a patient's heart for up to three years.

The news comes on the heels of the company's third-quarter earnings release. Although quarterly revenue rose 3.4% on a year-over-year basis to $4.16 billion, net income dropped by nearly the same percentage to land at $916 million ($0.91 per share).

Eric Volkman has no position in Medtronic. The Motley Fool owns shares of Medtronic. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Stocks Mentioned

Medtronic Plc Stock Quote
Medtronic Plc
MDT
$76.91 (-0.22%) $0.17

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.